[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK589089A - Anvendelse af benzomorphaner til cytoprotektion - Google Patents

Anvendelse af benzomorphaner til cytoprotektion

Info

Publication number
DK589089A
DK589089A DK589089A DK589089A DK589089A DK 589089 A DK589089 A DK 589089A DK 589089 A DK589089 A DK 589089A DK 589089 A DK589089 A DK 589089A DK 589089 A DK589089 A DK 589089A
Authority
DK
Denmark
Prior art keywords
benzomorphanes
cytoprotection
Prior art date
Application number
DK589089A
Other languages
English (en)
Other versions
DK589089D0 (da
Inventor
Adrian Carter
Helmut Ensinger
Herbert Merz
Enzio Mueller
Werner Stransky
Gerhard Walther
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of DK589089D0 publication Critical patent/DK589089D0/da
Publication of DK589089A publication Critical patent/DK589089A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK589089A 1988-11-24 1989-11-23 Anvendelse af benzomorphaner til cytoprotektion DK589089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3839659A DE3839659A1 (de) 1988-11-24 1988-11-24 Verwendung von benzomorphanen zur zytoprotektion

Publications (2)

Publication Number Publication Date
DK589089D0 DK589089D0 (da) 1989-11-23
DK589089A true DK589089A (da) 1990-05-25

Family

ID=6367798

Family Applications (1)

Application Number Title Priority Date Filing Date
DK589089A DK589089A (da) 1988-11-24 1989-11-23 Anvendelse af benzomorphaner til cytoprotektion

Country Status (7)

Country Link
EP (1) EP0370499A3 (da)
JP (1) JPH02193922A (da)
CA (1) CA2003572A1 (da)
DE (1) DE3839659A1 (da)
DK (1) DK589089A (da)
HU (1) HUT55231A (da)
ZA (1) ZA898936B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4222092A1 (de) * 1992-07-06 1994-01-13 Miele & Cie Backofen mit einem Kühlluftgebläse und/oder mit einem Heißluftgebläse
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
PL332413A1 (en) 1996-09-27 1999-09-13 Guilford Pharm Inc Compositions containing inhibitors of naaladase as well as methods of treating glutamatic anomaly and influencing neuronic functions among animals
DE19907874A1 (de) * 1999-02-23 2000-08-24 Boehringer Ingelheim Pharma N-(5-Phenyl-tetrahydrofuranyl)methyl- und N-(6-Phenyl-tetrahydropyranyl)methyl substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2014072809A2 (en) * 2012-11-09 2014-05-15 Purdue Pharma L.P. Benzomorphan analogs and the use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS166803B2 (da) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
GB8600783D0 (en) * 1986-01-14 1986-02-19 Merck Sharp & Dohme N-methyl-d-aspartate receptor antagonists

Also Published As

Publication number Publication date
ZA898936B (en) 1991-07-31
HU896152D0 (en) 1990-02-28
CA2003572A1 (en) 1990-05-24
EP0370499A3 (de) 1991-06-05
DE3839659A1 (de) 1990-05-31
EP0370499A2 (de) 1990-05-30
HUT55231A (en) 1991-05-28
DK589089D0 (da) 1989-11-23
JPH02193922A (ja) 1990-07-31

Similar Documents

Publication Publication Date Title
DK453789A (da) Fremgangsmaade til paavirkning af azopigmenters triboelektriske effekt
DK615988A (da) Fremgangsmaade til fremstilling af et afsvovlingsmiddel
DK250689A (da) Fremgangsmaade til fremstilling af napthalenderivater
DK214585D0 (da) Fremgangsmaade til fremstilling af imidazorifamyciner
DK107589A (da) Fremgangsmaade til fremstilling af difructosedianhydrid iii
DK30489A (da) Fremgangsmaade til fremstilling af pyranderivater
DK589089A (da) Anvendelse af benzomorphaner til cytoprotektion
DK601489D0 (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK28788D0 (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK314988A (da) Fremgangsmaade til fremstilling af 6-deoxyguaninderivater
DK53787D0 (da) Fremgangsmaade til fremstilling af carboxylsyreamider
DK143889A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK293589D0 (da) Fremgangsmaade til fremstiling af lactolderivater
DK533287A (da) Fremgangsmaade til fremstilling af azetidinoner
DK258886D0 (da) Fremgangsmaade til fremstilling af alkyloxiraner
DK599689A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK184789A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK184687D0 (da) Fremgangsmaade til fremstilling af diacetonesorbose
DK509986A (da) Fremgangsmaade til fremstilling af aryl-cyanamider
DK162789D0 (da) Fremgangsmaade til fremstilling af alkalimetalphenylpyruvat
DK130992D0 (da) Fremgangsmaade til fremstilling af angiotenxinomdannende enzyminhibitorer
DK142788D0 (da) Fremgangsmaade til fremstilling af chlorerede olefiner
DK564985D0 (da) Fremgangsmaade til fremstilling af alkylthioacetamidiner
DK646188A (da) Fremgangsmaade til fremstilling af halogenalkyllactamer
DK390887D0 (da) Fremgangsmaade til fremstilling af 7alfa-acetylthiosteroider

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment